Literature DB >> 14656840

Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study.

Jeptha P Curtis1, Yongfei Wang, Edward L Portnay, Frederick A Masoudi, Edward P Havranek, Harlan M Krumholz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14656840      PMCID： PMC286319          DOI： 10.1136/bmj.327.7427.1322

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Effect of ibuprofen on cardioprotective effect of aspirin.

Authors:  T M MacDonald; L Wei
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

2.  Parsing an enigma: the pharmacodynamics of aspirin resistance.

Authors:  Garret A FitzGerald
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

3.  Studying outcomes and hospital utilization in the elderly. The advantages of a merged data base for Medicare and Veterans Affairs hospitals.

Authors:  C Fleming; E S Fisher; C H Chang; T A Bubolz; D J Malenka
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

4.  Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.

Authors:  G T O'Connor; H B Quinton; N D Traven; L D Ramunno; T A Dodds; T A Marciniak; J E Wennberg
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272
  4 in total
  17 in total

1.  Giving aspirin and ibuprofen after myocardial infarction.

Authors:  Stephen E Kimmel; Brian L Strom
Journal:  BMJ       Date:  2003-12-06

Review 2.  Cardiology.

Authors:  Tom Fahey; Knut Schroeder
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

Review 3.  Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Authors:  Ruth Savage
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Pain management for dentists: the role of ibuprofen.

Authors:  Alessandro Pozzi; Luca Gallelli
Journal:  Ann Stomatol (Roma)       Date:  2012-04-15

5.  Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps.

Authors:  Harvey J Murff; Martha J Shrubsole; Zhi Chen; Walter E Smalley; Heidi Chen; Yu Shyr; Reid M Ness; Wei Zheng
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-15

6.  An overview of clinical pharmacology of Ibuprofen.

Authors:  Rabia Bushra; Nousheen Aslam
Journal:  Oman Med J       Date:  2010-07

7.  Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study.

Authors:  I L Meek; H E Vonkeman; J Kasemier; K L L Movig; M A F J van de Laar
Journal:  Eur J Clin Pharmacol       Date:  2012-08-14       Impact factor: 2.953

Review 8.  Celecoxib: a review of its use in the management of arthritis and acute pain.

Authors:  James E Frampton; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

Review 10.  Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis.

Authors:  Tobias Kurth; Charles H Hennekens; Julie E Buring; J Michael Gaziano
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.